Search Count: 20
 |
Human Wee1 Kinase In Complex With Inhibitor 1-[6-(1-Hydroxy-1-Methyl-Ethyl)-Pyridin-2-Yl]-2-(2-Methoxy-Phenyl)-6-[4-(4-Methyl-Piperazin-1-Yl)-Phenylamino]-1,2-Dihydro-Pyrazolo[3,4-D]Pyrimidin-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2023-05-31 Classification: TRANSFERASE Ligands: QT9 |
 |
Structure Of Human Plk1 In Complex With 2-Allyl-1-[6-(1-Hydroxy-1-Methyl-Ethyl)-Pyridin-2-Yl]-6-[4-(4-Methyl-Piperazin-1-Yl)-Phenylamino]-1,2-Dihydro-Pyrazolo[3,4-D]Pyrimidin-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2023-04-26 Classification: TRANSFERASE Ligands: ACT, 8X7, ZN |
 |
Hsp90 In Complex With 5-[4-(2-Fluoro-Phenyl)-5-Oxo-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl]-N-Furan-2-Ylmethyl-2,4-Dihydroxy-N-Methyl-Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6FJ |
 |
Hsp90 In Complex With 5-[4-(2-Fluoro-Phenyl)-5-Oxo-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl]-2,4-Dihydroxy-N-Methyl-N-Propyl-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6FF |
 |
Crystal Structure Of Hsp90-Alpha N-Domain In Complex With 5-(5-Bromo-2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2,4-Dihydro-[1,2,4]Triazol-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.22 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6DL |
 |
Crystal Structure Of Hsp90-Alpha N-Domain In Complex With 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2,4-Dihydro-[1,2,4]Triazol-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.38 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6G7 |
 |
Crystal Structure Of Hsp90-Alpha N-Domain In Complex With N-Butyl-5-[4-(2-Fluoro-Phenyl)-5-Oxo-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl]-2,4-Dihydroxy-N-Methyl-Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6GC |
 |
Crystal Structure Of Hsp90-Alpha N-Domain L107 Mutant In Complex With 5-[4-(2-Fluoro-Phenyl)-5-Oxo-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl]-N-Furan-2-Ylmethyl-2,4-Dihydroxy-N-Methyl-Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6FJ |
 |
Crystal Structure Of Hsp90-Alpha N-Domain L107A Mutant In Complex With 5-[4-(2-Fluoro-Phenyl)-5-Oxo-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl]-2,4-Dihydroxy-N-Methyl-N-Propyl-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6FF |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.17 Å Release Date: 2017-12-06 Classification: CHAPERONE |
 |
Crystal Structure Of Hsp90-Alpha N-Domain In Complex 5-[4-(2-Fluoro-Phenyl)-5-Oxo-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl]-2,4-Dihydroxy-N-Isopropyl-N-Methyl-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6GV |
 |
Crystal Structure Of Hsp90-Alpha N-Domain In Complex With 2,4-Dihydroxy-N-Methyl-5-(5-Oxo-4-O-Tolyl-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl)-N-Thiophen-2-Ylmethyl-Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6GW |
 |
Crystal Structure Of Hsp90-Alpha N-Domain L107A Mutant In Complex With 5-(5-Bromo-2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2,4-Dihydro-[1,2,4]Triazol-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6DL |
 |
Crystal Structure Of Hsp90-Alpha N-Domain L107A Mutant In Complex With 5-(2,4-Dihydroxy-Phenyl)-4-(2-Fluoro-Phenyl)-2,4-Dihydro-[1,2,4]Triazol-3-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6DL |
 |
Hsp90 In Complex With N-Butyl-5-[4-(2-Fluoro-Phenyl)-5-Oxo-4,5-Dihydro-1H-[1,2,4]Triazol-3-Yl]-2,4-Dihydroxy-N-Methyl-Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2017-12-06 Classification: CHAPERONE Ligands: 6GC, DMS |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2017-10-11 Classification: CHAPERONE |
 |
Crystal Structure Of Human Hsp70 Complexed With 4-{(2R,3S,4R)-5-[(R)-6-Amino-8-(3,4-Dichloro-Benzylamino)-Purin-9-Yl]-3,4-Dihydroxy-Tetrahydro-Furan-2-Ylmethoxymethyl}-Benzonitrile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.58 Å Release Date: 2013-12-18 Classification: CHAPERONE Ligands: 3FD |
 |
Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor 3-(4-Hydroxy-Phenyl)-1H-Indazol-6-Ol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2012-06-27 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: HH6, SO4 |
 |
Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor 3-Cyclohexyl-2-(6-Hydroxy-1H-Indazol-3-Yl)-Propionitrile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2012-06-27 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: EFT |
 |
Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor 6-Hydroxy-3-(3-Methyl-Benzyl)-1H-Indazole-5-Carboxylic Acid Benzyl-Methyl-Amide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2012-06-27 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: EFU, SO4 |